Searched for
MEDICINE PRICES
Supreme Court questions govt over drug pricing, asks why cap limited to anti-cancer medicinesThe Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning wh...- Assessing products to counter side effects of GLP-1, says Bayer's TrianaBayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...
- "These are facts Elon": Zoho cofounder Sridhar Vembu takes on Musk's claim of Starlink facing license hurdlesSridhar Vembu responded to Elon Musk's claims regarding regulatory obstacles for Starlink in India. Vembu highlighted India's competitive e...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Healthcare paradox: More access, but who pays?Scaling too fast is irrelevant. The real problem is that India still confuses more hospitals, more doctors and more medicines with better h...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
- Govt set to cap trade margins on more cancer drugs before SC hearingThe Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...
- Supreme Court seeks committee to curb pharma firms’ unethical marketing practicesThe Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns ove...
- Nandini milk price hike: Karnataka clears Rs 8 per litre hike, blue-packet toned milk may cost Rs 54; EC nod awaitedNandini milk prices: The prices of Nandini Milk are expected to rise by Rs 8 per litre, pending Election Commission clearance. This hike wi...
- Dabur expects double-digit Q2 revenue growth on strong India FMCG, overseas demandDabur India expects consolidated revenue to grow in double digits in the September quarter, supported by strong performance across its Indi...
- Hospital pricing part of wider value chain: Max MDAbhay Soi, chairman of Max Healthcare, commented on scrutiny regarding hospital pricing in India. He stated that hospitals should be evalua...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- Karnataka flags 52x mark-up on cancer drugs, seeks Centre's interventionKarnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...
- Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-upsHospital stocks came under pressure after the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospita...
- Iran's medicines soar in price as US blockade, sanctions squeeze pharmaceutical suppliesMedication prices in Iran have surged drastically due to US sanctions and ongoing conflict, creating significant hardships. Families are st...
- SC seeks 16% MRP cap on medicines, flags huge cancer drug markupsThe Supreme Court has raised concerns regarding inflated prices of essential medicines, particularly cancer drugs, sold at exorbitant marku...
- Cancer drug costs Rs 2,700, sells for Rs 27,000: SC questions 10x markup at hospitalsThe Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...
- Kerala HC says exorbitant drug prices can trigger government intervention in patented medicinesThe Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...
- 'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...
Load More
